|
Catalog Number AS-IFS1 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Stroke/CVA (1770)
|
Event Date 04/14/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional fda product code: gcj.Manufacturer narrative: the device will not be returned for evaluation and no photographic evidence was provided therefore root cause cannot be identified.A dhr review conducted by the vendor indicates (b)(4) devices were manufactured under the same work order and accepted into final stock in aug 2019 with no reported discrepancies.The service history was reviewed, and no data was found.(b)(4).Per the instructions for use, the user is advised that insufflation of co2 should be done carefully and while monitoring the patient's response.The user, particularly the anesthetist, should be informed about possible cardiovascular and respiratory problems of the patient and monitor these intra-operatively.The ifu also warns the user that insufflating co2 may result in metabolic acidosis.This can lead to cardiac irregularities expressed with the following symptoms: reduced aspiration with restricted diaphragm functions, hypercapnia and reduced cardiac output.This issue will continue to be monitored through the complaint system to assure patient safety.
|
|
Event Description
|
The customer reported that the device, as-ifs1, was being used during laparoscopic partial liver resection on (b)(6) 2021 when it was reported "after the surgery, the patient had stroke." the procedure had been completed when the stroke occurred.There was no report of device malfunction; only that the device had been used during the procedure.There was no report of any type of delay during the procedure and no report of an alternate device being used during the procedure.Further assessment questions were asked of the reporter; however, to date there has been no response.This report is being raised on the basis of injury due to patient having stroke after procedure.
|
|
Search Alerts/Recalls
|
|
|